Sunday, 25 September 2016

Abano Healthcare Group Limited Ordinary Shares

Recent Announcements
  • ABA Director Nomination Closing Date

    08:32 | 29/8/16
    NZX
    For the purposes of NZX Listing Rule 3.3.5, Abano Healthcare Group Limited advises that the closing date for director nominations is Monday 12 September 2016. All nominations must be received by 4.00 pm on the closing date. Nominations may only be made by a shareholder entitled to attend and vote at the Annual Meeting, and must be accompanied by the consent in writing of the nominated person. Nominations should be addressed to: Rache more»
  • Disclosure Notices

    11:25 | 26/8/16
    NZX
    Abano has provided ongoing disclosure notices for the following Abano directors and management: Andy Tapper Rachel Walsh Danny Chan Murray Boyte Pip Dunphy Trevor Janes Ted van Arkel End CA:00287978 For:ABA Type:RELINT Time:2016-08-26 11:25:07 more»
  • Abano Australian Investor Presentation

    08:32 | 25/8/16
    NZX
    Abano Healthcare Group is presenting to institutional investors in Australia today. A copy of the presentation is attached. End CA:00287840 For:ABA Type:ADDRESS Time:2016-08-25 08:32:20 more»
  • SSH Notice - Fisher Funds Management Limited

    11:20 | 24/8/16
    NZX
    Disclosure of movement of 1% or more in substantial holding or change in nature of relevant interest, or both Sections 277 and 278, Financial Markets Conduct Act 2013 Note: This form must be completed in accordance with the instructions at the end of the form. To New Zealand Exchange and To Abano Healthcare Group Ltd Relevant event being disclosed: Movement of 1% or more in the substantial holding Date of relevant event: 22 Augu more»
  • Abano Appoints Second Australian Director

    08:32 | 24/8/16
    NZX
    Abano Healthcare Group (NZX:ABA) has today announced the appointment of Dr Ginni Mansberg as an independent director effective from 24 August 2016. Dr Mansberg is a Sydney-based GP with a successful clinical practice. She is a member of the Australian Institute of Company Directors and sits on a number of corporate and not for profit Advisory Boards, including the Australian Cervical Cancer Foundation, and the Australian Immunization Coal more»
  • Notice of Issue of Shares Under DRP

    08:50 | 22/8/16
    NZX
    NOTICE PURSUANT TO LISTING RULE 7.12.1 22 August 2016 To: NZX Limited ORDINARY SHARES For the purposes of NZX Main Board Listing Rule 7.12.1, Abano Healthcare Group Limited advises the following in respect of the issue of new ordinary shares: Listing Rule 7.12.1 (a) Class of Security and ISIN: Fully paid ordinary shares. ISIN: NZNPEE0001S8 (b) Number issued: 194,282 ordinary shares (c) Nominal value/issue prices: $1,571,7 more»
  • Abano Announces DRP Strike Price

    09:04 | 19/8/16
    NZX
    Abano Healthcare Group Limited (NZX:ABA) advises that the strike price for shares issued in lieu of the cash 2016 Final Dividend under its Dividend Reinvestment Plan (DRP) is $8.09 per share. The issue price has been determined, in accordance with the DRP, as the volume weighted average sale price for all Abano shares sold on the NZX over the five trading days immediately following the record date of 11 August 2016, less a 2.5% discount.  more»
  • ABA 2016 Annual Report and Review

    13:57 | 8/8/16
    NZX
    Abano Healthcare Group is pleased to present the 2016 Annual Review. This accompanies the Financial Statements for the year ended 31 May 2016, which were released on 27 July 2016. The 2016 Annual Report will be available online at www.abano.co.nz/report. End CA:00286874 For:ABA Type:ANNREP Time:2016-08-08 13:57:41 more»
  • ABA Announces FY16 Results and Increased Dividend

    08:30 | 27/7/16
    NZX
    Healthcare investor, Abano Healthcare Group (NZX: ABA) has today released its financial results for the year ended 31 May 2016 reporting a Net Profit After Tax (NPAT) of $28.4m and a 33% increase in the final dividend to 20 cents per share. The full year results include a gain on sale of $20.2m on the $32m sale of Abano''s 50% shareholding in Bay International Limited. As this ceased to be recognised as an equity accounted investment from more»
  • ABA 2016 Results Advisory

    08:31 | 19/7/16
    NZX
    ABANO FULL YEAR RESULTS TO BE RELEASED ON 27 JULY 2016 Abano Healthcare Group (NZX:ABA) intends to announce its results for the financial year ended 31 May 2016 on Wednesday 27 July 2016, prior to 9am NZST. This will be followed by an analyst and investor conference call at 10.00am NZST to review the FY16 results and discuss the Company''s outlook for the 2017 financial year. To attend the conference call, participants will need to d more»
Global Indices
CodeLastChange
NZ507,297150.20%
COMP5,306340.63%
DJI18,2611310.71%
SP5002,165120.57%
DAX10,627470.44%
FTSE6,90920.03%
NI22516,754540.32%
TWI75.590.450.59%
No news available...
Currencies
CodeLastChange
EURUSD1.1230.0020.13%
NZDUSD0.72410.00700.96%
AUDUSD0.76170.00300.39%
NZDAUD0.95000.00560.59%